Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic merkel cell carcinoma

Please use this identifier to cite or link to this item: https://doi.org/10.1200/JCO.2009.21.8149

DC Field	Value
dc.title	Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic merkel cell carcinoma
dc.contributor.author	Davids, M.
dc.contributor.author	Charlton, A.
dc.contributor.author	Ng, S.-S.
dc.contributor.author	Chong, M.-L.
dc.contributor.author	Soong, R.
dc.contributor.author	Laubscher, K.
dc.contributor.author	Dar, M.
dc.contributor.author	Hodge, J.
dc.contributor.author	Goh, B.C.
dc.date.accessioned	2011-09-29T05:54:41Z
dc.date.available	2011-09-29T05:54:41Z
dc.date.issued	2009
dc.identifier.citation	Davids, M., Charlton, A., Ng, S.-S., Chong, M.-L., Soong, R., Laubscher, K., Dar, M., Hodge, J., Goh, B.C. (2009). Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic merkel cell carcinoma. Journal of Clinical Oncology 27 (26). ScholarBank@NUS Repository. https://doi.org/10.1200/JCO.2009.21.8149
dc.identifier.issn	0732183X
dc.identifier.uri	http://scholarbank.nus.edu.sg/handle/10635/27284
dc.description.uri	http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1200/JCO.2009.21.8149
dc.source	Scopus
dc.type	Article
dc.contributor.department	PHARMACOLOGY
dc.description.doi	10.1200/JCO.2009.21.8149
dc.description.sourcetitle	Journal of Clinical Oncology
dc.description.volume	27
dc.description.issue	26
dc.identifier.isiut	000269652200034
Appears in Collections:	Staff Publications

There are no files associated with this item.

Check